David Smith

Development by design methodology: the key to successful manufacturing of patient-specific cell therapies

11 July 2017 | By Brian Hampson, David Smith

Recognised as the next wave of medicine, cell therapies have made significant strides over the last several years. But such advancements can present unique challenges, especially as more products move out of the clinic and toward commercialisation. And unlike typical pharmaceuticals, cell therapies rely heavily on the manufacturing process to…